P2/3 starting soon, confidence in ODD, and strong P1 data, Relyvrio being pulled and a less superior sale anchor at $2.4B
We should only be wanting the price to increase if you have finished buying.
Im happy for it to sit low right now while I accumulate. You don't get many short term chances like this while the market is asleep.
Very different biotech here than hoping your cancer drug in a saturated market, with side effects, and 500+ other trials is going to make it through.
Don't waste this opportunity.
P2/3 starting soon, confidence in ODD, and strong P1 data,...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.90M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.0¢ | 20.0¢ | $191.1K | 906.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1300 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 9563 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
21.0¢ |
Change
0.000 ( 6.67 %) |
||||
| Open | High | Low | Volume | ||
| 22.0¢ | 22.5¢ | 20.5¢ | 533029 | ||
| Last updated 15.54pm 03/05/2024 ? | |||||
| PAA (ASX) Chart |